60 Degrees Pharmaceuticals, Stock Performance
| SXTP Stock | 0.51 0.04 7.27% |
The firm owns a Beta (Systematic Risk) of 1.17, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, 60 Degrees will likely underperform. At this point, 60 Degrees Pharmaceu has a negative expected return of -1.49%. Please make sure to confirm 60 Degrees' total risk alpha, as well as the relationship between the kurtosis and price action indicator , to decide if 60 Degrees Pharmaceu performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days 60 Degrees Pharmaceuticals, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2026. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
Last Split Factor 1:5 | Last Split Date 2025-02-24 |
1 | 60 Degrees Pharmaceuticals Inc. Equity Warrant stock daily chart insights - 2025 Volatility Report Daily Oversold Bounce Ideas - newser.com | 10/20/2025 |
2 | How 60 Degrees Pharmaceuticals Inc. stock reacts to bond yields - 2025 Buyback Activity Fast Momentum Stock Entry Tips - fcp.pa.gov.br | 11/05/2025 |
3 | Is 60 Degrees Pharmaceuticals Inc. stock oversold or undervalued - July 2025 Institutional Accurate Technical Buy Alerts - newser.com | 11/11/2025 |
4 | 60 Degrees Pharmaceuticals Stock Rating Upgraded by Zacks Research | 11/20/2025 |
5 | Acquisition by Xu Cheryl of 1500 shares of 60 Degrees at 1.58 subject to Rule 16b-3 | 11/24/2025 |
6 | Is 60 Degrees Pharmaceuticals Inc. stock a defensive play in 2025 - 2025 Top Gainers Capital Efficient Trading Techniques - B NI V | 11/26/2025 |
7 | Acquisition by Geoffrey Dow of 9350 shares of 60 Degrees at 0.9504 subject to Rule 16b-3 | 12/10/2025 |
8 | 60 Degrees Pharmaceuticals Announces Expansion of ARAKODA Sales and Marketing in 2026 | 12/11/2025 |
9 | Acquisition by Geoffrey Dow of 9670 shares of 60 Degrees at 0.8024 subject to Rule 16b-3 | 12/15/2025 |
10 | Why 60 Degrees Pharmaceuticals Inc. stock is considered a top pick - July 2025 Levels Fast Entry and Exit Trade Plans - | 12/18/2025 |
11 | Heres Why 60 Degrees Pharmaceuticals Inc. Looks Ripe for Bottom Fishing | 12/23/2025 |
12 | 60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study ... | 12/29/2025 |
| Begin Period Cash Flow | 2.1 M | |
| Total Cashflows From Investing Activities | -1.9 M |
60 Degrees Relative Risk vs. Return Landscape
If you would invest 147.00 in 60 Degrees Pharmaceuticals, on October 1, 2025 and sell it today you would lose (96.00) from holding 60 Degrees Pharmaceuticals, or give up 65.31% of portfolio value over 90 days. 60 Degrees Pharmaceuticals, is currently does not generate positive expected returns and assumes 5.7192% risk (volatility on return distribution) over the 90 days horizon. In different words, 51% of stocks are less volatile than SXTP, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
60 Degrees Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for 60 Degrees' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as 60 Degrees Pharmaceuticals,, and traders can use it to determine the average amount a 60 Degrees' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2612
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SXTP |
Based on monthly moving average 60 Degrees is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 60 Degrees by adding 60 Degrees to a well-diversified portfolio.
60 Degrees Fundamentals Growth
SXTP Stock prices reflect investors' perceptions of the future prospects and financial health of 60 Degrees, and 60 Degrees fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SXTP Stock performance.
| Return On Equity | -1.55 | ||||
| Return On Asset | -0.7 | ||||
| Operating Margin | (4.40) % | ||||
| Current Valuation | 7.94 M | ||||
| Shares Outstanding | 4.23 M | ||||
| Price To Sales | 1.71 X | ||||
| Revenue | 607.57 K | ||||
| Gross Profit | 585.86 K | ||||
| EBITDA | (7.88 M) | ||||
| Net Income | (7.96 M) | ||||
| Total Debt | 155.89 K | ||||
| Book Value Per Share | (1.25) X | ||||
| Cash Flow From Operations | (5.65 M) | ||||
| Earnings Per Share | (0.78) X | ||||
| Market Capitalization | 2.34 M | ||||
| Total Asset | 5.76 M | ||||
| Retained Earnings | (40.53 M) | ||||
| Working Capital | 3.73 M | ||||
About 60 Degrees Performance
Assessing 60 Degrees' fundamental ratios provides investors with valuable insights into 60 Degrees' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the 60 Degrees is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 420.02 | 451.39 | |
| Return On Tangible Assets | (1.42) | (1.49) | |
| Return On Capital Employed | (2.37) | (2.25) | |
| Return On Assets | (1.38) | (1.45) | |
| Return On Equity | (1.97) | (1.87) |
Things to note about 60 Degrees Pharmaceu performance evaluation
Checking the ongoing alerts about 60 Degrees for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for 60 Degrees Pharmaceu help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| 60 Degrees Pharmaceu generated a negative expected return over the last 90 days | |
| 60 Degrees Pharmaceu has high historical volatility and very poor performance | |
| 60 Degrees Pharmaceu has some characteristics of a very speculative penny stock | |
| 60 Degrees Pharmaceu has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 607.57 K. Net Loss for the year was (7.96 M) with profit before overhead, payroll, taxes, and interest of 585.86 K. | |
| 60 Degrees generates negative cash flow from operations | |
| Latest headline from globenewswire.com: 60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State |
- Analyzing 60 Degrees' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether 60 Degrees' stock is overvalued or undervalued compared to its peers.
- Examining 60 Degrees' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating 60 Degrees' management team can have a significant impact on its success or failure. Reviewing the track record and experience of 60 Degrees' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of 60 Degrees' stock. These opinions can provide insight into 60 Degrees' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for SXTP Stock Analysis
When running 60 Degrees' price analysis, check to measure 60 Degrees' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 60 Degrees is operating at the current time. Most of 60 Degrees' value examination focuses on studying past and present price action to predict the probability of 60 Degrees' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 60 Degrees' price. Additionally, you may evaluate how the addition of 60 Degrees to your portfolios can decrease your overall portfolio volatility.